Exhibitor

Bedfont Scientific Ltd

Boehringer Ingelheim

Bedfont Scientific Ltd. has specialised in the design and manufacture of exhaled breath and gas monitoring instruments since 1976.
For over 30 years, our Smokerlyzer® range of carbon monoxide (CO) monitors has been helping people to quit smoking – one of the largest contributing factors to COPD.
Bedfont® also manufactures the NObreath FeNO monitor, which measures airway inflammation to improve asthma management. Using FeNO measurements to evaluate airway inflammation in asthma represents a significant advance in respiratory medicine, but until now this has been an expensive test to deliver in everyday practice.
Some patients with COPD also show symptoms of asthma, suggesting they have asthma-COPD overlap syndrome, more commonly known as ACOS.

Visit: www.bedfont.com

« Go Back

Supporting Publication
Organised by
 
  • Elsevier
  • CHEST
Lead Medical and Scientific Sponsor
 
Boehringer Ingelheim
Exhibitor
 
bedfont